development of a new antimicrobial drug based on quaternary ammonium compounds

This study presents the development of quatersan, a novel disinfectant based on quaternary ammonium compounds (qacs) with enhanced antimicrobial properties. through systematic screening of 270 synthesized compounds, we identified 53 exhibiting antimicrobial activity, with 7 showing particularly high efficacy against clinically relevant pathogens. the lead compound demonstrated superior performance with minimum inhibitory concentrations (mic) of 0.05 mg/ml against staphylococcus aureus atcc 6538, 0.07 mg/ml against escherichia coli atcc 25922, and 0.10 mg/ml against candida albicans atcc 10231 - representing a 2-4 fold improvement over standard chlorhexidine. structure-activity analysis revealed that antimicrobial potency strongly correlates with halogen radical presence in 2-halopyridine-3-carbonitrile derivatives. comprehensive evaluation including serial passage experiments confirmed no resistance development in test strains after 30 generations. industrial trials demonstrated 98.5% disinfection efficacy across different surfaces (metal, plastic, and wood), with complete material compatibility and competitive cost-efficiency at $0.20/m². toxicological assessment classified quatersanas category iii (moderately hazardous) per who guidelines, with no observed skin irritation or tissue damage. these findings position quatersan as a promising next-generation disinfectant combining: broad-spectrum antimicrobial activity, resistance prevention, and practical advantages for clinical and veterinary applications.